QQ客服 官方微博 反馈留言

	Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients
	Liu, Lei; Guo, Renbo; Zhang, Xiang; Liang, Yiran; Kong, Feng; Wang, Jue; Xu, Zhonghua
刊名	BIOSCIENCE TRENDS
	2017
卷号	11期号:2页码:214-220
关键词	SET domain-containing protein 2 clear cell renal cell carcinoma H3K36me3 prognosis
DOI	10.5582/bst.2016.01228
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4589041
专题	山东大学
作者单位	1.Shandong Univ, Qilu Hosp, Inst Basic Med Sci, Jinan, Shandong, Peoples R China. 2.[L
推荐引用方式 GB/T 7714	Liu, Lei,Guo, Renbo,Zhang, Xiang,et al. Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients[J]. BIOSCIENCE TRENDS,2017,11(2):214-220.
APA	Liu, Lei.,Guo, Renbo.,Zhang, Xiang.,Liang, Yiran.,Kong, Feng.,...&Xu, Zhonghua.(2017).Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients.BIOSCIENCE TRENDS,11(2),214-220.
MLA	Liu, Lei,et al."Loss of SETD2, but not H3K36me3, correlates with aggressive clinicopathological features of clear cell renal cell carcinoma patients".BIOSCIENCE TRENDS 11.2(2017):214-220.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。